Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

  • Peter Matthews1Email author,
  • Marc Alpert2,
  • Galia Rahav3,
  • Denise Rill4,
  • Edward Zito4,
  • David Gardiner4,
  • Ron Pedersen4,
  • Timothy Babinchak4,
  • Paul C McGovern4 and
  • , for the Tigecycline 900 cSSSI Study Group
BMC Infectious Diseases201212:297

DOI: 10.1186/1471-2334-12-297

Received: 4 November 2011

Accepted: 1 November 2012

Published: 12 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
4 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Dec 2011 Reviewed Reviewer Report - RAVINA KULLAR
9 Jan 2012 Reviewed Reviewer Report - Warren Rose
12 Jul 2012 Author responded Author comments - Peter Matthews
Resubmission - Version 3
12 Jul 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
10 Oct 2012 Reviewed Reviewer Report - RAVINA KULLAR
19 Oct 2012 Reviewed Reviewer Report - Warren Rose
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
1 Nov 2012 Editorially accepted
12 Nov 2012 Article published 10.1186/1471-2334-12-297

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Family Medicine, Department of Health
(2)
Central Montgomery Surgical Associates
(3)
Chaim Sheba Medical Center, Infectious Disease Unit
(4)
Pfizer Inc

Advertisement